New light-sensitive protein enables simpler, more powerful optogenetics.
Optogenetics, a technology that allows scientists to control brain activity by shining light on neurons, relies on light-sensitive proteins that can suppress or stimulate electrical signals within cells. This technique requires a light source to be implanted in the brain, where it can reach the cells to be controlled.
MIT engineers have now developed the first light-sensitive molecule that enables neurons to be silenced noninvasively, using a light source outside the skull. This makes it possible to do long-term studies without an implanted light source. The protein, known as Jaws, also allows a larger volume of tissue to be influenced at once.
This noninvasive approach could pave the way to using optogenetics in human patients to treat epilepsy and other neurological disorders, the researchers say, although much more testing and development is needed.
Read more . . .
The Latest on: Noninvasive brain control
[google_news title=”” keyword=”Noninvasive brain control” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Noninvasive brain control
- Chronic alcohol use is linked to impaired plasticity of brain inhibition networks, study suggestson March 28, 2024 at 3:00 am
Brain stimulation was found to enhance inhibitory control in healthy adults but failed to improve inhibitory control in those with alcohol use disorder, suggesting chronic alcohol use alters the brain ...
- Elon Musk's brain chip: restoring sight to blind monkeyson March 25, 2024 at 11:00 am
Elon Musk's brain chip restores sight to blind monkeys, promises superior vision to human eye; research breakthroughs continue.
- Neuralink's Brain Chip Is Running in a Human. Your Skull Is Safe, for Nowon March 22, 2024 at 5:59 am
On March 20, the company streamed live video of that patient, now identified as Noland Arbaugh, playing online chess on a laptop, using the brain chip to move the cursor on the screen. "Basically, it ...
- Video shows first Neuralink brain chip patient playing chess by moving cursor with thoughtson March 22, 2024 at 5:53 am
In a livestream on X, Noland Arbaugh, the first human to get Elon Musk's Neuralink cybernetic implant, moved a computer cursor with his mind.
- Watch Elon Musk's first Neuralink patient play chess with his mindon March 21, 2024 at 7:06 am
Neuralink went live on X Wednesday, sharing a clip of its first patient playing chess with his mind. Noland Arbaugh, a 29-year-old quadriplegic, is the first human to receive a Neuralink device.
- New study reveals breakthrough in understanding brain stimulation therapieson March 20, 2024 at 4:25 pm
Researchers show that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior.
- Despite symptoms, NIH research finds no evidence of ‘Havana syndrome’ in brain scanson March 18, 2024 at 7:00 am
Researchers with the National Institutes of Health published a pair of studies on Monday that found few clinical differences between patients with a mysterious ailment known as “Havana syndrome” and ...
- Non-invasive brain stimulation can change specific brain mechanism linked to human behavioron March 16, 2024 at 9:53 am
For the first time, researchers at the University of Minnesota Twin Cities showed that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior.
- Is Elon Musk’s Brain Chip Neuralink Fiction Or The Future? Here’s All You Need To Knowon March 15, 2024 at 9:37 am
Imagine a world where your thoughts control your devices. No more typing, swiping or even speaking. Elon Musk‘s Neuralink, a brain chip implant, promises this mind-blowing leap into the future. By ...
- Specialized MRI may predict who will develop treatment-resistant schizophreniaon March 15, 2024 at 8:20 am
Specialized brain scans may accurately predict whether a psychotic patient will go on to develop treatment-resistant schizophrenia, Dutch researchers report.
via Bing News